通过优化在线消化中下蛋白质学方法解锁糖蛋白IgE的宏分子蛋白质异质性的复杂性
Ruijie Liu1, Zixin Liang1, Shujun Xia1
1School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
Analytica chimica acta
|February 18, 2026
概括
中下蛋白质组学 (MDP) 推进了像免疫球蛋白E (IgE) 这样的大型蛋白质的分析. 这种新平台能够详细描述IgE蛋白质形式及其糖化,这对于了解过敏性疾病至关重要.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
背景情况:
- 由于大小和异质性,分析像免疫球蛋白E (IgE) 这样的大型修饰蛋白质是很困难的.
- 传统的蛋白质组学方法缺乏用于蛋白质形式水平分析的细节.
- 中下蛋白质组学 (MDP) 通过分析较大的片段提供了一个解决方案.
研究的目的:
- 开发一个改进的中下蛋白质组学 (MDP) 平台,用于分析大蛋白质异质性.
- 将这个平台应用于免疫球蛋白E (IgE) 进行全面的表征.
主要方法:
- 开发了一个在线,可调节的素消化平台,用于快速的MDP.
- 应用该平台来分析免疫球蛋白E (IgE).
- 利用高冗余性来进行 de novo 测序和糖化分析.
主要成果:
- 该平台使IgE可变区域的de novo测序成为可能.
- 鉴定了39个IgE的常数区域3 (Cε3) 域蛋白形体.
- 提供了有关IgE糖化,包括组成,占用率和微异质性的详细见解.
结论:
- MDP方法提供了对IgE异质性的整体观点,整合了序列和糖基化数据.
- 这对于理解IgE在过敏性疾病中的作用以及开发诊断和治疗方法至关重要.
- 开发的工作流程增强了MDP对各种大型蛋白质的多功能性.
相关概念视频
Protein Digestion
Protein digestion begins in the stomach, where the highly acidic environment can easily disrupt protein structure by exposing the peptide bonds of polypeptide chains. After polypeptide chains are broken into individual amino acids by a series of digestive enzymes, the amino acids are transported to the liver via the bloodstream to produce energy.
Carbohydrate Digestion
Carbohydrate digestion and metabolism break down simple and complex carbohydrates from food into saccharides (i.e., sugars) for the body to use as energy. Carbohydrate digestion starts in the mouth during mastication, or chewing. The masticated carbohydrates remain intact in the stomach. Digestion resumes in the duodenum of the small intestine, where pancreatic alpha-amylase and brush border enzymes of the microvilli convert complex carbohydrates to monosaccharides. Finally, the monosaccharides...
GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...


